Shenzhen Kangtai Biological Products announced that due to significant changes in the current Industry environment, market operation environment, and other internal and external factors compared to when the incentive plan was launched, it will be difficult to achieve the intended incentive goals and effects by continuing to implement this incentive plan. To better protect the interests of the company, Shareholders, and employees, and in accordance with the company's actual situation and future development plans, after careful study, the company intends to terminate the implementation of this incentive plan, cancel the stock options, and invalidate the restricted stocks. At the same time, related documents that accompany this plan will also be terminated. This proposal still needs to be submitted to the company’s Shareholders' meeting for deliberation.
康泰生物:终止实施2023年股票期权与限制性股票激励计划
Shenzhen Kangtai Biological Products: Termination of the implementation of the 2023 Stock Options and Restricted Stock Incentive Plan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.